By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Peninsula Pharmaceuticals, Inc. 

1701 Harbor Bay Parkway

Alameda  California  94502  U.S.A.
Phone: 510-747-3900 Fax:



Company News
East Bay Biotechs Hit Sales Block 1/3/2006 11:44:06 AM
The Day In Review: Acquisitions Help Biotech10/19/2005 5:13:13 PM
Johnson & Johnson (JNJ) Announces Agreement; Ortho-McNeil Pharmaceutical, Inc. A Subsidiary Of Johnson & Johnson To Acquire Peninsula Pharmaceuticals, Inc.; $245 Million In Cash10/19/2005 5:13:08 PM
Peninsula Pharmaceuticals, Inc. Enters Into Discussions To Be Acquired; Delayed The Pricing Of Its Initial Public Offering10/19/2005 5:12:40 PM
Peninsula Pharmaceuticals, Inc. Announces Abstracts To Be Presented At The 44th Annual Interscience Conference On Antimicrobial Agents And Chemotherapy 10/19/2005 5:11:59 PM
FDA Grants Peninsula Pharmaceuticals, Inc. Fast Track Designation For Doripenem10/19/2005 5:11:57 PM
Peninsula Pharmaceuticals, Inc. Completes Phase 1 Clinical Trial For PPI-0903 - A Novel Cephalosporin With In-vitro Activity Against Resistant Gram-positive Bacteria10/19/2005 5:11:46 PM
Peninsula Pharmaceuticals, Inc. Commences Phase I Clinical Trial For PPI-090310/19/2005 5:11:27 PM
Peninsula Pharmaceuticals, Inc. Appoints Keith Katkin As Vice President Of Commercial Development10/19/2005 5:11:17 PM
Peninsula Pharmaceuticals, Inc. Elects David H. MacCallum To Its Board Of Directors10/19/2005 5:11:06 PM